Induced proximity drugs target specific protein interactions

Induced proximity drugs, which force proteins to interact that normally wouldn't, are gaining traction. This biotech approach helps control cellular processes by either building up or breaking down specific proteins. It's a new way to target diseases that traditional drugs can't reach, opening doors for therapies in areas like neurodegeneration and inflammation.